Acción A243070 HUONS CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Huons Co., Ltd.

Acciones

A243070

KR7243070000

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 03/05/2024 		Varia. Cinco días. Varia. 1 de enero.
34.950 KRW +0,58 % Gráfico intradía de Huons Co., Ltd. +1,75 % -8,98 %
20/03 Huons Co., Ltd. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023 CI
2023 Huons Co. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2022 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
South Korea's Huons to Export Anesthetics to Canada
GenEdit Inc. amended terms of the transaction
South Korean Stocks Turn Upbeat as China COVID-19 Lockdown Restrictions Ease; Huons Adds 1%
Huons to Invest $18.3 Million to Raise Production Capacity for Injectable Products at Jecheon Plant
GenEdit Inc. announced that it expects to receive $30 million in funding
Haemato : to Seek EU Approval for Botox Product
PanGen Biotech Inc. announced that it has received KRW 9.99998571 billion in funding from Huons Co., Ltd. and another investor
PanGen Biotech Inc. announced that it expects to receive KRW 9.99998571 billion in funding from Huons Co., Ltd., and another investor
Pharmcadd Co, Ltd announced that it has received $16 million in funding from a group of investors
Master Meditech Inc. announced that it has received KRW 8 billion in funding from Samho Green Investment, Inc., Paratus Investment Inc., Spring Camp, Huons Co., Ltd., Pharmbio Co., Ltd., INNOCENCE Co.Ltd
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
Huons Co., Ltd.'s Equity Buyback announced on August 14, 2020, has expired with 80,102 shares, representing 0.74% for KRW 4,989.56 million.
LIPAC Oncology Announces Major Partnering Milestone Achieved in Its License Agreement with Huons Co., Ltd
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A243070
  4. Noticias Huons Co., Ltd.
  5. Otros idiomas